Renal cancers are highly aggressive and clinically challenging, but a transgenic mouse model to promote pathologic studies and therapeutic advances has yet to be established. on April 13,
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Page: 5 degradation (8) . The interaction of HIF1Į with pVHL is mediated by hydroxylation of two proline residues (P402, 564) in the oxygen-dependent degradation domain (9, 10) . Under hypoxic conditions, these proline residues are not hydroxylated. HIF1Į, therefore, can't be recognized by pVHL and becomes stabilized. Dimerization of the stabilized HIF1Į with the constitutively active HIF1ȕ results in binding of the HIF heterodimer complex to hypoxia responsive elements (HRE, consensus sequence: 5'-RCGTG-3') (11) . Under normoxic conditions HIF1Į is also hydroxylated at a conserved asparagine residue (N803) by factor inhibiting HIF1Į (FIH-1), whose activity is also oxygen-dependent (12) . The asparaginyl hydroxylation prevents recruitment of p300 and the transcriptional co-activator protein CBP, resulting in attenuated transcription of HIF1Į target genes by HIF1Į (13) . Since the asparaginyl hydroxylation is also oxygen dependent, under hypoxic conditions HIF1Į is not inhibited by FIH-1 and can activate transcription. Mutation of these three key amino acids should mimic hypoxic conditions by preventing HIF1Į from being degraded by pVHL and by allowing HIF1Į to recruit p300 and CBP, resulting in constitutive expression of HIF1Į target genes.
Few mouse models that exhibit the pertinent features of human VHL disease in the kidney exist. Recapitulation of human kidney carcinogenesis by inactivation of the human tumor suppressor gene VHL has not been achieved (14) (15) (16) . We created a triple mutant (P402A, P564A, N803A) human HIF1Į construct using the kidney proximal tubule specific type 1 γ-glutamyl transpeptidase(GGT or γGT) promoter (17, 18) to drive expression of this triple mutant, constitutively active HIF1Į in the proximal tubule cells (PTCs). Mice expressing this triple mutant, constitutively active HIF1Į construct in the kidney exhibit "clear" cells, renal cysts, disorganized PTs, and cystic clear cell carcinoma, consistent with ccRCC. HIF1Į paper.
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Immunostaining
Immunohistochemistry and immunofluorescence were performed (22) . Antibodies: HIF1Į (610958, BD-Transduction); CA-IX (sc-25600, Santa Cruz); Glut-1 (ab14683, Abcam, Cambridge, MA); VEGF (sc-507, Santa Cruz); Cd-31 (550274, BD Pharmingen, San Diego, CA); PCNA (M0879, Dako, Carpinteria, CA) and ȖH2AX (9718S, Cell Signaling, Danvers, MA).
Cd-31 was stained on cryo-preserved, frozen sections. Periodic Acid/Schiff (PAS) stain was performed on paraffin-embedded (23) and cryo-preserved sections. Oil red O (ORO) staining was also performed (24) .
Statistical Analysis
Results are expressed as mean ± SEM. Student's t test was used to determine the statistical significance of the ȖH2AX + and Ki67 + cell number differences between TG + and TG -mice.
HIF1Į paper.
Page: 8
Results
Generation of transgenic mice expressing mutated, constitutively active HIF1Į
A high level of HIF1Į protein is a prominent feature of ccRCC (8) . Furthermore, increased expression of HIF1Į and/or HIF2Į, which has 48% amino acid homology with HIF1Į, is thought to be a key event in ccRCC carcinogenesis (3) . To examine the role of HIF1Į in ccRCC carcinogenesis we constructed a GGT-HIF1Į triple mutant plasmid (Ȗ-HIF1Į-M3, Fig.   1A ). After confirmation of activity in cultured normal kidney proximal tubule cells, Ȗ-HIF1Į-M3 transgenic mice were generated from the γHIF1α-M3 plasmid. Five of 51 founder mice harbored the integrated target gene (Fig. 1B , founders #8 to #14). Four lines were evaluated by RT-PCR, using a transgene specific primer pair (primers 1 and 2, Fig. 1A ) for kidney, spleen, liver, heart, lung, intestine, skeletal muscle, and testis/ovary mutant HIF1Į mRNA. Fig. 2A , black arrows), and prominent cell membranes, a feature of human ccRCC ( Fig. 2A) . We identified two types of vacuolation: large round, discrete vacuoles displacing the nucleus ( Fig. 2A , solid black arrow), and vacuoles with pale, eosinophilic to clear feathery cytoplasm without displacement of the nucleus ( Fig. 2A, dashed black arrow). The morphology of the large round, discrete vacuoles is consistent with lipid accumulation, while the morphology of the feathery cytoplasm is consistent with glycogen accumulation and hydropic degeneration. These "clear" cell clusters were morphologically strikingly similar to early lesions reported to occur in the "normal" kidneys of patients with VHL disease (6) . Since the GGT promoter only drives the expression of the transgene in the PTs, we did not expect abnormalities in the renal medulla or papilla and did not observe any morphological abnormalities in these regions (not shown). Not all PTs contained these "clear" cell clusters; areas of "normal" PTs were present in the cortex, as assessed by histological morphology ( Fig. 2A, yellow arrow) . "Clear" cell PTs covered about 30% of the cortex in the 6 The multiple renal cysts observed (26) in VHL disease patients are believed to be precursors of ccRCC (1, 27) . We identified cysts composed of a single layer of epithelial cells in 12 month TG + mice (Fig. 3A) . Dilated blood vessels filled with red blood cells were typically found near cysts. The majority of the cysts had clear spaces within, while some cysts contained amorphous, pale, eosinophilic material ( (Table 1) . Twenty-two month-old TG + mice had cystic ccRCC (Fig. 3E ). VHL kidney disease features such as "clear" cells, renal cysts, hyperchromatic nuclei, disorganized PTs, and cystic ccRCC were not observed in TG -mice ( Fig.   3F ).
Ȗ-HIF1Į-M3-43 TG + murine kidneys molecularly resemble human VHL kidney disease.
In ccRCC there is increased vascularization surrounding tumor cells (28 We detected increased Glut-1 in the basal and lateral membranes of the "clear" cells of abnormal PTs (Fig. 4C ), but not in the luminal membranes/brush borders in the Ȗ-HIF1Į-M3-43 TG + mice. We also observed a stronger Glut-1 signal in some membranes surrounding the clear vacuoles (Fig. 4C, arrow) . The "normal" PTs in TG + kidneys, which are similar in morphology to normal PTs in TG -kidneys, show much weaker Glut-1 staining (Fig. 4D ).
We detected increased VEGF staining, assessed by immunohistochemistry, in the cytoplasm of the "clear" cells in the abnormal PTs (Fig. 4E ) in the Ȗ-HIF1Į-M3-43 TG + mice. In some "clear" cells we detect intense VEGF staining close to empty vacuoles (Fig. 4E , arrow).
The morphologically "normal" PT cells in TG + mice exhibit lower VEGF staining, similar to the normal PTs in TG -mice (Fig. 4F ).
Ȗ-HIF1Į-M3-43 TG + mice express Ki67 and ȖH2AX, molecular markers of carcinogenesis.
Proliferating Cell Nuclear Antigen (PCNA) is an essential component of DNA polymerase į (35) and is expressed during S phase of the cell cycle; Ki67 is a marker for proliferation (36) . We detected increased numbers of PCNA + or Ki67 + cells in the morphologically abnormal PTs of TG + mice (Fig. 5A, arrows) , but not in the "normal" PTs. In TG -mice, we saw few PCNA + (not shown) or Ki67 + cells in the PTs (Fig. 5B, TG-) .
Genomic instability is another universal feature of tumor cells (37) . Premalignant and malignant cells accumulate more mutations than normal cells (37) . An increased DNA mutation rate/genomic instability may facilitate neoplastic transformation (38) . Since the DNA mutation rate is difficult to measure, we measured the numbers of DNA double strand breaks (DSBs) in (Fig. 6 ). We observe "clear" cell morphological abnormalities and increased expression of CA-IX, and ȖH2AX in PT cells in these additional 3 TG + lines (Fig. 6A , B, C). We detect increased Ki67 in the Ȗ-HIF1Į-M3-32 line, the line that expresses the second highest level of HIF1Į protein (Fig. 6D) . We also observe renal cysts in older TG + mice (Fig. 6E) . Thus, the phenotype we describe here is the result of mutant, constitutive HIF1Į overexpression. 
HIF1Į activation can induce genomic instability and cell proliferation.
A most interesting observation in the Ȗ-HIF1Į-M3 TG + lines is the induction of DNA DSBs in a small percentage of "clear" cells, as indicated by ȖH2AX staining (Fig. 5C, E) . DNA DSBs can induce genomic instability and carcinogenesis (46) . Almost every DNA DSB forms a ȖH2AX + focus, and therefore ȖH2AX is used to detect DNA DSBs (39 
HIF1Į activation can induce VHL disease in the kidney.
Renal cysts are observed in more than 60% of VHL disease patients and are thought to be precursors of ccRCC (1). The "clear" cells in the disorganized PTs of TG + mice (Fig. 3D ) are between the stages of carcinoma in situ and frank carcinoma. However, we did not detect late stage ccRCC with invasion and metastasis in TG + mice. CD70 protein is upregulated in the majority of human ccRCC and is a marker of early human ccRCC (34) . CD70 mRNA was higher in older TG + mice relative to TG -controls (Fig. 4I ). This result suggests that there may be some neoplastically transformed, "clear" cells present. Cigarette smoking, obesity, and hypertension are three well-established risk factors for ccRCC (48) . We are testing these TG + mice to determine if exposure to these conditions results in more rapid neoplastic transformation of PT cells in our TG + mice.
Our results suggest that activated HIF1Į functions as an oncogene in clear cell renal 
HIF1Į in VHL disease, especially in ccRCC carcinogenesis, is of interest because HIF1Į is directly regulated by pVHL, which is usually lost or silenced in ccRCC (3) . In an earlier publication, when pVHL expression was restored in VHL -/-human ccRCC cells tumorigenesis in a xenograft tumor model was blocked, and stabilization of HIF1Į alone didn't reproduce the tumor phenotype in these ccRCC cells expressing ectopic pVHL (49) . However, HIF1Į is not fully activated in this model (49) because hydroxylation of the asparagine(N803) can still occur.
Moreover, fully tumorigenic ccRCC cells were used in a xenograft model so the carcinogenesis process was not analyzed (49) . In contrast, our TG + mice allow us to follow the carcinogenesis process over time and assess the early molecular changes that occur.
In summary, our results indicate that this constitutively active HIF1Į functions as an oncogene in renal carcinogenesis. Expression of a mutated, constitutively active HIF1Į protein in kidney PTs results in a phenotype similar to that observed in patients with VHL disease, including premalignant lesions, multiple renal cysts, and ccRCC.
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